Volpes R, Burra P, Germani G, Manini M, Caccamo L, Strignano P
Health Qual Life Outcomes. 2020; 18(1):99.
PMID: 32276633
PMC: 7149917.
DOI: 10.1186/s12955-020-01349-5.
Park G, Hwang S, Kim M, Jung D, Song G, Lee K
J Korean Med Sci. 2020; 35(6):e36.
PMID: 32056398
PMC: 7025905.
DOI: 10.3346/jkms.2020.35.e36.
Muthiah M, Tan E, Chua S, Huang D, Bonney G, Kow A
Hepatol Int. 2020; 14(1):57-69.
PMID: 31919678
DOI: 10.1007/s12072-019-10011-2.
Platt L, French C, McGowan C, Sabin K, Gower E, Trickey A
J Viral Hepat. 2019; 27(3):294-315.
PMID: 31603999
PMC: 7383613.
DOI: 10.1111/jvh.13217.
Hwang S, Song G, Chung Y, Ahn C, Kim K, Moon D
J Korean Med Sci. 2019; 34(38):e251.
PMID: 31583871
PMC: 6776838.
DOI: 10.3346/jkms.2019.34.e251.
The efficiency of low-dose hepatitis B immunoglobulin plus nucleos(t)ide analogs in preventing posttransplant hepatitis B virus recurrence.
Vatansever S, Farajov R, Yilmaz H, Zeytunlu M, Kilic M
Turk J Med Sci. 2019; 49(4):1019-1024.
PMID: 31385669
PMC: 7018359.
DOI: 10.3906/sag-1808-86.
Assessment of patient safety and the efficiency of facility utilization following simplified ultra-rapid intravenous infusion of hepatitis B immunoglobulin in a high-volume liver transplantation center.
Jeong I, Hwang S, Jung D, Song G, Park G, Ahn C
Ann Hepatobiliary Pancreat Surg. 2019; 23(2):128-132.
PMID: 31225413
PMC: 6558124.
DOI: 10.14701/ahbps.2019.23.2.128.
Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis.
Beckebaum S, Herzer K, Bauhofer A, Gelson W, De Simone P, de Man R
Ann Transplant. 2018; 23:789-801.
PMID: 30420590
PMC: 6249983.
DOI: 10.12659/AOT.910176.
A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis.
Han S, Na G, Kim D
Drug Des Devel Ther. 2017; 11:2099-2107.
PMID: 28744101
PMC: 5513836.
DOI: 10.2147/DDDT.S134711.
Hepatitis B virus and its sexually transmitted infection - an update.
Inoue T, Tanaka Y
Microb Cell. 2017; 3(9):420-437.
PMID: 28357379
PMC: 5354569.
DOI: 10.15698/mic2016.09.527.
Pediatric liver transplantation: predictors of survival and resource utilization.
Wagenaar A, Tashiro J, Sola J, Ekwenna O, Tekin A, Perez E
Pediatr Surg Int. 2016; 32(5):439-49.
PMID: 27001031
DOI: 10.1007/s00383-016-3881-6.
Application of nucleoside analogues to liver transplant recipients with hepatitis B.
Song Z, Cui Y, Zheng W, Teng D, Zheng H
World J Gastroenterol. 2015; 21(42):12091-100.
PMID: 26576094
PMC: 4641127.
DOI: 10.3748/wjg.v21.i42.12091.
Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation.
Ishigami M, Ogura Y, Hirooka Y, Goto H
World J Gastroenterol. 2015; 21(36):10290-8.
PMID: 26420956
PMC: 4579876.
DOI: 10.3748/wjg.v21.i36.10290.
Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation.
Khemichian S, Hsieh M, Zhang S, Limurti J, Kim J, Fong T
Dig Dis Sci. 2015; 60(9):2807-12.
PMID: 25939541
DOI: 10.1007/s10620-015-3671-3.
Safety of Complete and Sustained Prophylaxis Withdrawal in Patients Liver-transplanted for Hepatitis B Virus-related Cirrhosis at Low Risk of Hepatitis B Virus Recurrence.
Lenci I, Tisone G, DiPaolo D, Duseja A
J Clin Exp Hepatol. 2015; 1(2):122-3.
PMID: 25755326
PMC: 3940384.
DOI: 10.1016/S0973-6883(11)60134-5.
Clinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experience.
Zhang D, Jiao Z, Han J, Cao H
Int J Clin Exp Pathol. 2014; 7(7):4057-66.
PMID: 25120784
PMC: 4129019.
Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections.
Kovacs Jr C, Koval C, van Duin D, de Morais A, Gonzalez B, Avery R
World J Transplant. 2014; 4(2):43-56.
PMID: 25032095
PMC: 4094952.
DOI: 10.5500/wjt.v4.i2.43.
Anti-HBs response to hepatitis B immunoglobulin prophylaxis in liver transplant recipients.
Varghese J, Reddy M, Cherian T, Vijaya S, Jayanthi V, Rela M
Indian J Gastroenterol. 2014; 33(3):226-30.
PMID: 24760685
DOI: 10.1007/s12664-014-0457-z.
Prophylaxis of hepatitis B infection in solid organ transplant recipients.
John S, Andersson K, Kotton C, Hertl M, Markmann J, Cosimi A
Therap Adv Gastroenterol. 2013; 6(4):309-19.
PMID: 23814610
PMC: 3667476.
DOI: 10.1177/1756283X13487942.
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B.
Perrillo R, Buti M, Durand F, Charlton M, Gadano A, Cantisani G
Liver Transpl. 2013; 19(8):887-95.
PMID: 23788462
PMC: 3791551.
DOI: 10.1002/lt.23690.
